These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10407230)

  • 21. Sample-size calculation and reestimation for a semiparametric analysis of recurrent event data taking robust standard errors into account.
    Ingel K; Jahn-Eimermacher A
    Biom J; 2014 Jul; 56(4):631-48. PubMed ID: 24817598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable.
    Whitehead AL; Julious SA; Cooper CL; Campbell MJ
    Stat Methods Med Res; 2016 Jun; 25(3):1057-73. PubMed ID: 26092476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blinded sample size recalculation in clinical trials with binary composite endpoints.
    Sander A; Rauch G; Kieser M
    J Biopharm Stat; 2017; 27(4):705-715. PubMed ID: 27295402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample size and interim analysis issues for dose selection.
    Lee KL
    Am Heart J; 2000 Apr; 139(4):S161-5. PubMed ID: 10740124
    [No Abstract]   [Full Text] [Related]  

  • 25. Sample size reassessment in non-inferiority trials. Internal pilot study designs with ANCOVA.
    Friede T; Kieser M
    Methods Inf Med; 2011; 50(3):237-43. PubMed ID: 20213039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothesis testing for two-stage designs with over or under enrollment.
    Zeng D; Gao F; Hu K; Jia C; Ibrahim JG
    Stat Med; 2015 Jul; 34(16):2417-26. PubMed ID: 25809924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An internal pilot design for prospective cancer screening trials with unknown disease prevalence.
    Brinton JT; Ringham BM; Glueck DH
    Trials; 2015 Oct; 16():458. PubMed ID: 26463684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of single-arm vs. randomized phase II clinical trials: a Bayesian approach.
    Sambucini V
    J Biopharm Stat; 2015; 25(3):474-89. PubMed ID: 24896838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of adaptive designs for single-armed phase II oncology trials.
    Kieser M; Englert S
    J Biopharm Stat; 2015; 25(3):602-15. PubMed ID: 24905363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A small n sequential multiple assignment randomized trial design for use in rare disease research.
    Tamura RN; Krischer JP; Pagnoux C; Micheletti R; Grayson PC; Chen YF; Merkel PA
    Contemp Clin Trials; 2016 Jan; 46():48-51. PubMed ID: 26586608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A seamless phase II/III design with sample-size re-estimation.
    Bischoff W; Miller F
    J Biopharm Stat; 2009 Jul; 19(4):595-609. PubMed ID: 20183428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal sample sizes for phase II clinical trials and pilot studies.
    Stallard N
    Stat Med; 2012 May; 31(11-12):1031-42. PubMed ID: 22052407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statistical power and sample size requirements for three level hierarchical cluster randomized trials.
    Heo M; Leon AC
    Biometrics; 2008 Dec; 64(4):1256-62. PubMed ID: 18266889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A framework for prospectively defining progression rules for internal pilot studies monitoring recruitment.
    Hampson LV; Williamson PR; Wilby MJ; Jaki T
    Stat Methods Med Res; 2018 Dec; 27(12):3612-3627. PubMed ID: 28589752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A three-outcome design for randomized comparative phase II clinical trials.
    Hong S; Wang Y
    Stat Med; 2007 Aug; 26(19):3525-34. PubMed ID: 17262879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accounting for variability in sample size estimation with applications to nonadherence and estimation of variance and effect size.
    Fay MP; Halloran ME; Follmann DA
    Biometrics; 2007 Jun; 63(2):465-74. PubMed ID: 17688499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of the two-sample t-test statistic following blinded sample size re-estimation.
    Lu K
    Pharm Stat; 2016 May; 15(3):208-15. PubMed ID: 26865383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re-calculating the sample size in internal pilot study designs with control of the type I error rate.
    Kieser M; Friede T
    Stat Med; 2000 Apr; 19(7):901-11. PubMed ID: 10750058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the importance of calculating sample size?
    Patino CM; Ferreira JC
    J Bras Pneumol; 2016 Apr; 42(2):162. PubMed ID: 27167443
    [No Abstract]   [Full Text] [Related]  

  • 40. A SAS macro for sample size re-estimation.
    Zellner D; Zellner GE; Keller F
    Comput Methods Programs Biomed; 2001 Jun; 65(3):183-90. PubMed ID: 11339980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.